Michael Lee-Chin

National Commercial Bank Jamaica Ltd. engages in the provision of commercial banking and financial services. It operates its business through following segments: Retail and Small and Medium-Sized Enterprises (SMEs); Payment Services; Corporate Banking; Treasury and Correspondent Banking; Wealth, Asset Management, and Investment Banking; Life Insurance and Pension Fund Management; General Insurance; and Other. The Retail and SMEs segment incorporates the provision of banking services to individual and small and medium business clients, and money remittance services. The Payment Services segment focuses on the provision of card related services. The Corporate Banking segment deals with the provision of banking services to large corporate clients. The Treasury and Correspondent Banking segment includes the company's liquidity and investment management function, management of correspondent bank relationships, and relationships with other financial institutions as well as foreign currency dealing activities. The Wealth, Asset Management, and Investment Banking segment engages in the provision of stock brokerage, securities trading, investment management, and other financial services. The Life Insurance and Pension Fund Management segment incorporates life insurance, pension, and investment management services. The General Insurance segment focuses on the provision of property and casualty insurance services. The Other segment deals with the brokerage services, trustee services, and registrar and transfer agent services. The company was founded in 1837 and is headquartered in Kingston, Jamaica.

Part of The Bank of Nova Scotia, Regal Capital Planners Ltd is a Canadian company that provides financial advisory services. The company is based in Waterloo, Canada. Regal Capital Planners was acquired by Cartier Partners Financial Group, Inc. on April 20, 2000 for $29.95 million.

Bp Trinidad & Tobago LLC engaged in the exploration and production of oil and gas to the design and construction of platforms and the installations of pipelines. The company was founded in 2001 and is headquartered in Port of Spain, Trinidad and Tobago.

Royal Ontario Museum operates museums. The company is headquartered in Toronto, Canada.

Portland Private Equity LP (Portland Private Equity) is a private equity firm founded in 2007. The firm is headquartered in Saint Michael, Barbados.

Portland Holdings, Inc. is a Canadian company that provides investment services. The private company is based in Burlington, CA. and has subsidiaries in Canada, Trinidad and Tobago and United States.

Portland Investment Counsel, Inc. is an SEC-registered investment advisor located in Mississauga, Ontario with an additional office in Burlington, Ontario. The firm manages the AIC Advantage Fund, the AIC Diversified Canada Fund, the AIC Canadian Focused Fund, the AIC Diversified Canada Corporate Class, the AIC Canadian Focused Corporate Class, the AIC Global Financial Split Corp., the AIC Preferred Income Fund, the AIC Advantage Fund II, the AIC Advantage II Corporate Class, the AIC Global Advantage Corporate Class, the AIC American Advantage Fund, the AIC Global Advantage Fund and the AIC Global Wealth Management Fund.

The Trinidad & Tobago Manufacturers' Association functions as a trade association. The private company is based in Trinidad and Tobago.

Mandeville Holdings, Inc. provides investment advisory services. The firm serves individuals, institutions, foundations and not-for-profit organizations. The company was founded by Michael Anthony Lee-Chin and is headquartered in Burlington, Canada.

ITM Isotopen Technologien München AG develops diagnostic and therapeutic radionuclides and radiopharmaceuticals. Its products include EnolucinBeta, 188w/188re generator, 255AC/213Bi Generator, IQS-TS, IQS, consumables, and GMP Radiolabeling service. The company was founded in 2004 and is headquartered in Garching, Germany.

RadioMedix, Inc. is a clinical stage biotechnology company based in Houston, TX, focused on innovative targeted radiopharmaceuticals for diagnosis, monitoring, and therapy of cancer. The private company commercializes radiopharmaceuticals for PET imaging and targeted alpha and beta-emitter therapy. The company covers the entire value chain from drug discovery to sponsoring and conducting clinical trials. The company has established contract service facilities for academic and industrial partners, including a drug discovery center, pre-clinical core facility, and a CGMP manufacturing and analytical suite for human clinical trials and commercial phase manufacturing of the radiopharmaceuticals. The company has also established a large-scale post-approval commercial manufacturing facility known as the Spica Center. The company's pipeline includes Detectnet™, a diagnostic agent for management of somatostatin expressing neuroendocrine cancers using PET/CT technology. The company was founded by Ebrahim S. Delpassand and he has been the CEO since incorporation.